Wockhardt’s Illinois Drug Firm Closed In FDA Settlement After GMP Problems Found Since 2011

Permanent injunction states Morton Grove Pharmaceuticals intends to sell its facility. Complaint comes more than 10 years after first of five inspections found GMP problems.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation